APA (7th ed.) Citation

Kehr, D., Salatzki, J., Seger, B., Varadi, K., Birkenstock, J., Schlegel, P., . . . Most, P. (2025). Cardiac-targeted AAV5-S100A1 gene therapy protects against adverse remodeling and contractile dysfunction in postischemic hearts. Circulation. Heart failure, 18(7), . https://doi.org/10.1161/CIRCHEARTFAILURE.124.012479

Chicago Style (17th ed.) Citation

Kehr, Dorothea, et al. "Cardiac-targeted AAV5-S100A1 Gene Therapy Protects Against Adverse Remodeling and Contractile Dysfunction in Postischemic Hearts." Circulation. Heart Failure 18, no. 7 (2025). https://doi.org/10.1161/CIRCHEARTFAILURE.124.012479.

MLA (9th ed.) Citation

Kehr, Dorothea, et al. "Cardiac-targeted AAV5-S100A1 Gene Therapy Protects Against Adverse Remodeling and Contractile Dysfunction in Postischemic Hearts." Circulation. Heart Failure, vol. 18, no. 7, 2025, https://doi.org/10.1161/CIRCHEARTFAILURE.124.012479.